Nithro is a principal investment vehicle. We deploy our own capital, structure transactions using our AGI governance engine NUT, and help companies access public markets through direct listings. We take no advisory fees. Our returns come from outcomes.
Most capital structures separate the people who structure a deal from those who bear its consequences. Nithro does not. Every transaction we engage with is one in which we have committed our own capital. This single discipline shapes everything — how we select opportunities, how patiently we structure them, and how consistently we remain involved after closing.
We work with a small number of counterparties at any time, chosen because we believe the combination of our capital, network, and NUT infrastructure creates a meaningfully better outcome than any alternative arrangement.
A small number of principles guide every decision at Nithro. They are not slogans — they are the constraints within which we operate.
Companies that reach public markets through traditional underwritten IPOs pay a significant portion of their entire raise to a syndicate of banks for price discovery and distribution. For many companies, this cost is avoidable. Direct listings — in which existing shares trade freely from day one without an underwriter guaranteeing the price — represent a structurally cleaner outcome for founders and long-term investors.
Nithro provides capital through a company's growth journey using our Living Equity structure. By listing time, the company is not dependent on IPO proceeds for operational capital. NUT publishes independent valuations throughout, so the market arrives at pricing with genuine, documented information.
Nithro does not underwrite securities and does not arrange securities transactions. Our role is capital provision, preparation, and independent research publication. Companies preparing for listing should appoint appropriately authorised advisers for regulated aspects of the process.
Four distinct activities, governed by the same principle: we deploy our own capital and are accountable to the outcome.
NUT is Nrutseab's proprietary AGI architecture — designed for governance, interpretability, and human oversight. At Nithro, it is the engine behind every valuation, structure, and deal.
Nithro publishes NUT-generated valuations for portfolio companies and, selectively, for companies preparing for direct listings. These publications are proprietary research outputs produced by an AI system operating on a documented methodology.
They do not constitute regulated financial advice, investment recommendations, or solicitations to invest. They are not produced by a person authorised to give regulated investment advice. Anyone relying on NUT outputs for investment purposes should do so only as one input among many, after obtaining independent regulated advice appropriate to their circumstances.
The methodology underlying NUT valuations is disclosed in summary form on request. Nithro does not accept liability for decisions made on the basis of published valuations.
Nito is Nrutseab's institutional vehicle for minority stake investments, M&A, and strategic partnerships. Nithro and Nito operate as complementary components of a single principal capital ecosystem.
The relationship between Nithro and Nito is governed by a formal partnership agreement. Nithro and Nito are legally distinct entities with separate governance structures, mandates, and capital pools.
Material conflicts of interest between the two entities are managed under a written conflicts policy and disclosed to relevant counterparties prior to engagement. A formal information barrier policy governs the flow of information between the two entities.
A full account of what Nithro is, what it is not, and how we operate within applicable law — in plain language.
Nithro Capital Ltd is a private limited company registered in England and Wales. It is a wholly-owned subsidiary of Nrutseab Ltd.
Nithro Capital Ltd is not authorised or regulated by the Financial Conduct Authority (FCA) or any other regulatory body as an investment firm, financial adviser, broker-dealer, or collective investment scheme operator.
Nithro does not conduct regulated activities as defined under the Financial Services and Markets Act 2000 (FSMA) or the Financial Services and Markets Act 2000 (Regulated Activities) Order 2001. In particular, Nithro does not:
All capital deployed by Nithro is proprietary capital of Nithro Capital Ltd or its parent. Co-investment opportunities are extended exclusively to persons who qualify as eligible counterparties or professional investors under applicable law, and are made available under applicable private placement exemptions.
The content of this website has not been approved by an authorised person for the purposes of section 21 of FSMA. The website is directed only at persons to whom a communication may lawfully be made without such approval, including persons outside the United Kingdom and persons within the United Kingdom who fall within an applicable exemption under the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005. If you are a retail client in the United Kingdom, you should not rely on the information on this website for investment purposes.
Valuations published by Nithro using the NUT engine are proprietary research outputs produced by an automated system. They are not produced by a person authorised to provide regulated investment advice. They do not constitute investment advice, recommendations to buy or sell any security, or solicitations to invest. They are provided for informational purposes only. Nithro accepts no liability for any loss arising from reliance on NUT valuation outputs.
Nithro's direct listing preparation service consists of capital provision, governance preparation, and the publication of independent research. Nithro does not act as an underwriter, sponsor, nominated adviser, or placing agent in connection with any listing. Companies preparing for a listing should obtain their own regulated legal and financial advice and, where required, appoint appropriately authorised advisers for regulated aspects of the listing process.
Nithro Capital Ltd and Nito are legally distinct entities. A formal information barrier policy governs the flow of information between the two entities. Nithro maintains a conflicts register. Where a material conflict of interest exists or may exist in relation to a specific transaction or counterparty, this will be disclosed in writing prior to engagement.
Nithro processes personal data in accordance with the UK General Data Protection Regulation (UK GDPR) and the Data Protection Act 2018. We collect only the information necessary to respond to enquiries and conduct due diligence on proposed counterparties. We do not sell or share personal data with third parties for marketing purposes. To exercise your rights under UK GDPR, contact [email protected].
This website and all matters relating to Nithro Capital Ltd are governed by the laws of England and Wales. The courts of England and Wales have exclusive jurisdiction in relation to any dispute arising from or in connection with this website or Nithro's activities.
For regulatory, legal, or compliance enquiries: [email protected]
We respond to all enquiries personally. If you are approaching us about a transaction, a brief description of what you are looking to achieve is helpful.
For investment discussions, NUT valuation requests, direct listing preparation, and partnership opportunities.
[email protected]We aim to respond within two business days. All communications are treated as confidential unless you indicate otherwise.
For media enquiries and requests relating to the Nrutseab documentary project.
[email protected]For regulatory and legal correspondence.
[email protected]By submitting this form you confirm you have read our privacy policy. This form does not constitute a binding engagement or investment offer.